Treatment of Gaucher's disease with OGT 918.
Kranda
M
M
D017485:1-Deoxynojirimycin / Q000008:administration & dosage* / Q000009:adverse effects* / Q000031:analogs & derivatives; D000284:Administration, Oral; D004791:Enzyme Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects*; D005776:Gaucher Disease / Q000188:drug therapy* / Q000378:metabolism; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D013995:Time; D016896:Treatment Outcome
D004791:Enzyme Inhibitors; D065089:Glycoside Hydrolase Inhibitors; D017485:1-Deoxynojirimycin; C059896:miglustat